Investigation of the potential anticancer effects of napelline and talatisamine dirterpenes on experimental brain tumor models.

Cytotechnology
Merve Demirbağ Karaali, Elanur Aydın Karataş

Abstract

Brain cancers are one of the most aggressive tumours in humans. Especially, gliomas are among the deadliest of human cancers and show high resistance to chemotherapeutic agents. On the other hand, discovery of biologically effective non-synthetic biomaterials in treatments of different diseases, especially cancer, has continued to be one of the most popular research topics today. Therefore, we aimed to investigate biochemical, cytological and molecular genetic effects of napelline and talatisamine diterpenes in human U-87 MG glioma cells by using total antioxidant status and total oxidative status, 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxphenyl)-2-(4-sulfophenyl)-2H-tetrozolium, inner salt and lactate dehydrogenase release assay and RT2 Prolifer PCR Arrays. Our results revealed that napelline and talatisamine exhibited cytotoxic effects at high doses. Napelline and talatisamine diterpenes increased apoptosis compared to control in U-87 MG cells. While napelline induced up-regulation of 50 and down-regulation of 13 genes, talatisamine induced up-regulation of 32 and down-regulation of 18 genes in U-87 MG cells. Napelline was shown to have a higher anticancer activity than talatisamine. We think that, napelline and talatis...Continue Reading

References

Nov 25, 1983·Journal of Immunological Methods·C Korzeniewski, D M Callewaert
Nov 5, 1997·Science·J C Sacchettini, C D Poulter
Oct 9, 1999·Clinical Microbiology Reviews·M M Cowan
Jun 23, 2001·BMJ : British Medical Journal·A G RenehanC S Potten
May 27, 2004·The Journal of Pharmacology and Experimental Therapeutics·Masuo KondohYoshiteru Watanabe
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Nov 23, 2006·Chemical Research in Toxicology·Yee Y Lee-HilzIvonne M C M Rietjens
Jun 28, 2007·Current Oncology·W P MasonUNKNOWN Canadian GBM Recommendations Committee
Jul 5, 2007·Molecular Interventions·Yumin ChenDaret K St Clair
Jul 20, 2007·Phytotherapy Research : PTR·Koneni V SashidharaNaibedya Chattopadhyay
Nov 13, 2007·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·F BakkaliM Idaomar
Jul 26, 2008·Nature Nanotechnology·Dan PeerRobert Langer
Nov 26, 2008·Bioorganic & Medicinal Chemistry Letters·P Prabhakar ReddyJ Madhusudana Rao
Feb 2, 2010·Chemical & Pharmaceutical Bulletin·Ji-Young HongSang Kook Lee
Sep 22, 2010·Journal of Korean Neurosurgical Society·Chang-Hyun LeeSeung Hoon Lee
Apr 5, 2013·Toxicology and Industrial Health·Elanur AydinMevlüt Sait Keles
Oct 3, 2013·Arhiv za higijenu rada i toksikologiju·Elanur AydinSener Taşdemir
Nov 19, 2013·International Immunopharmacology·Fatemeh AlizadehSepideh Arbabi Bidgoli
Jan 28, 2015·Advanced Biomedical Research·Majid KheirollahiParvin Mahzouni
Mar 31, 2015·Cancers·Meena Jhanwar-UniyalRaj Murali
Apr 1, 2011·Israel Journal of Chemistry·Emily C Cherney, Phil S Baran
Sep 25, 2015·Journal of Intercultural Ethnopharmacology·Basak TogarFatime Geyikoglu
Nov 9, 2015·Cytotechnology·Pollyanna Francielli de OliveiraDenise Crispim Tavares
Jun 17, 2016·Phytotherapy Research : PTR·Md Torequl IslamAna Amélia de Carvalho Melo-Cavalcante
Dec 22, 2017·Acta Biologica Hungarica·Tivadar KissZsolt László Datki

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.